Bharat Biotech
Polio Vaccine
Biopolio B1/3 Oral Vaccine is used in the prevention of polio, protecting against poliomyelitis causing poliovirus.
Oral Solution
Biopolio B1/3 Oral Vaccine is used in the prevention of polio. It protects against poliomyelitis causing poliovirus. Polio or poliomyelitis is a crippling and potentially deadly infectious disease. The virus spreads from person to person and can invade an infected person's brain and spinal cord, causing paralysis.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Biopolio B1/3 Oral Vaccine may be taken with or without food but it is better to take it at a fixed time.
No common side effects listed.
It is not known whether it is safe to consume alcohol with Biopolio B1/3 Oral Vaccine. Please consult your doctor.
Information regarding the use of Biopolio B1/3 Oral Vaccine during breastfeeding is not available. Please consult your doctor. Biopolio B1/3 Oral Vaccine is not indicated for use in adults.
Information regarding the use of Biopolio B1/3 Oral Vaccine during pregnancy is not available. Please consult your doctor.
Azathioprine Mercaptopurine Methotrexate Mycophenolate mofetil
Biopolio B1/3 Oral Vaccine contains live attenuated Poliomyelitis type 1 & type 3 viruses. It works by provoking the immune system to produce antibodies (proteins) without actually causing a disease. In the event of infection, these antibodies prevent the spread of the virus to the brain and protect against paralysis.
Biopolio B1/3 Oral Vaccine is given for the prevention of polio disease. Biopolio B1/3 Oral Vaccine must be administered by oral route only Biopolio B1/3 Oral Vaccine must be taken with an oral dropper supplied with the vaccine vial. Inform your doctor if your child is suffering from a high fever or any acute illness.
Children typically receive four doses of Biopolio B1/3 Oral Vaccine. The first dose is administered at two months of age, followed by the next doses at 4 months, 6–18 months, and 4–6 years, respectively. However, in some cases, Biopolio B1/3 Oral Vaccine may be combined with other vaccines, leading to a fifth dose being administered.
Biopolio B1/3 Oral Vaccine contains live attenuated poliovirus (strains 1 and 3) and is intended for polio prophylaxis in infants aged 6-12 weeks, all unimmunized children up to 18 years of age, and high-risk adults. Adults should receive the inactivated poliovirus vaccine (IPV).
Polio vaccines are vaccines used to prevent poliomyelitis (polio). There are two types: inactivated poliovirus vaccine (IPV), administered via injection, and weakened oral poliovirus vaccine (OPV), given orally.
Yes, polio virus can attack the nervous system leading to paralysis, particularly of lower limbs. Therefore, obtaining Biopolio B1/3 Oral Vaccine is crucial for providing protection against this virus.
No, IPV is considered more effective than Biopolio B1/3 Oral Vaccine. While it is less expensive and easier to administer than Biopolio B1/3 Oral Vaccine, it was observed that administering Biopolio B1/3 Oral Vaccine alone led to a higher incidence of polio compared to IPV.